Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: April 2011
-
April 13-15, 2011 – Intellectual Property Counsels Committee (IPCC) Spring Conference & Meeting (Biotechnology Industry Organization) – Seattle, WA April 15, 2011 – 2nd Annual John Marshall Law School Review of Intellectual Property Law Symposium – Chicago, IL April 27, 2011 – 27th Annual Joint Patent Practice Seminar (Connecticut, New Jersey, New York, and Philadelphia…
-
International Quality & Productivity Center (IQPC) will be holding its 7th Patent Strategies Summit from April 27-29, 2011 in Palo Alto, CA. The summit will cover the following topics: • Changes in patent strategy brought about by the current economic downturn;• Best practices in global IP management;• Prospects for the future in light of new…
-
C5 (UK) will be holding its 8th International Forum on Freedom to Operate on May 18-19, 2011 in Munich, Germany. The conference will provide insights on FTO challenges and updates, including: • Executing successful and cost-effective search strategies;• Enforcing or defending patent claims in new markets;• Challenging validity to overcome blocking patents;• Capitalizing on the…
-
By Kevin E. Noonan — The Myriad case (AMP v. USPTO) came to the Federal Circuit on Monday for oral argument, and after months of briefing and public comment the parties did not deviate from their well-established positions (with the possible exception of Solicitor General Neal Katyal, whose argument for the government has become even…
-
By Donald Zuhn — In a notice of proposed rulemaking published in today's Federal Register (76 Fed. Reg. 18990), the U.S. Patent and Trademark Office announced a proposal to revise the patent term adjustment (PTA) and patent term extension (PTE) provisions of the patent rules. In particular, the Office is proposing changes to the PTA…
-
By James DeGiulio — Cephalon's Fentora Patent Found Valid, Infringed by Watson Cephalon enjoyed a needed victory in its patent dispute with Watson over Fentora after one of the patents at issue in the case was upheld and Watson's proposed generic of Fentora was found to infringe that patent. The dispute between the parties began…
-
By Kevin E. Noonan — Think tanks, consortia, foundations, subcommittees, and "working groups" frequently assay an area with some social, economic, or technological significance to determine whether issues exist or can be anticipated that deserve to be studied to minimize harm or maximize opportunity. These groups can be helpful in focusing attention of what may…
-
By Kevin E. Noonan — On Monday, the Federal Circuit hears oral argument in Association of Molecular Pathology v. U.S. Patent and Trademark Office (aka the Myriad case). In addition to the parties (Appellant Myriad Genetics and Appellees represented by the American Civil Liberties Union and the Public Patent Foundation), the Court has granted leave…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Senju Pharmaceutical Co. Ltd. et al. v. Lupin Ltd. et al.1:11-cv-00271; filed March 31, 2011 in the District Court of Delaware • Plaintiffs: Senju Pharmaceutical Co. Ltd.; Kyorin Pharmaceutical Co. Ltd.; Allergan Inc.• Defendants: Lupin…
-
April 5-6, 2011 – International Patent Forum 2011 (Managing Intellectual Property) – London, UK April 6-9, 2011 – 26th Annual Intellectual Property Law Conference (American Bar Association Section of Intellectual Property Law) – Arlington, VA April 7, 2011 – "The Oral Argument in Myriad" (Intellectual Property Owners Association) – 2:00 PM (ET) April 13-15, 2011…
Patent Docs 